Guerbet SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guerbet SA with three other
companies in this sector in France:
sales of 350.35 million Euro [US$412.18 million]
of which 76%
(871.83 million Euro [US$1.03 billion]
of which 58%
was Companion Animals), and
(614.49 million Euro [US$722.93 million]
of which 51%
was Non-Proprietary Homeopathic Medicines).
During the year ended December of 2016, sales at
Guerbet SA were 775.77 million Euro (US$912.67 million).
increase of 58.7%
versus 2015, when the company's sales were 488.74 million Euro.
This was the third consecutive year of growth at Guerbet SA.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
393.8% in 2016, from
4.40 million Euro to 21.72 million Euro.
Guerbet SA also saw significant increases in sales in
X-Rays (up 78.2% to 375.47 million Euro)
Medical Devices (Md) (up 257.2% to 76.80 million Euro)